These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 29485002)

  • 1. Emerging Roles of Purinergic Signaling in Diabetes.
    Fotino C; Dal Ben D; Adinolfi E
    Med Chem; 2018; 14(5):428-438. PubMed ID: 29485002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
    Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
    Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenosinergic system: a potential player in the pathogenesis of ANCA-associated vasculitis?
    Kling L; Krämer BK; Yard BA; Kälsch AI
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):143-151. PubMed ID: 29745882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adenosine generating enzymes CD39/CD73 control microglial processes ramification in the mouse brain.
    Matyash M; Zabiegalov O; Wendt S; Matyash V; Kettenmann H
    PLoS One; 2017; 12(4):e0175012. PubMed ID: 28376099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic signaling in the pancreas and the therapeutic potential of ecto-nucleotidases in diabetes.
    Cieślak M; Roszek K
    Acta Biochim Pol; 2014; 61(4):655-62. PubMed ID: 25522227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent regulatory roles of extracellular ATP in the degranulation response of mouse bone marrow-derived mast cells.
    Yoshida K; Ito M; Matsuoka I
    Int Immunopharmacol; 2017 Feb; 43():99-107. PubMed ID: 27988461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the CD39-CD73-adenosine pathway in liver disease.
    Wang S; Gao S; Zhou D; Qian X; Luan J; Lv X
    J Cell Physiol; 2021 Feb; 236(2):851-862. PubMed ID: 32648591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
    Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
    Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered E-NTPDase/E-ADA activities and CD39 expression in platelets of sickle cell anemia patients.
    Castilhos LG; Doleski PH; Adefegha SA; Becker LV; Ruchel JB; Leal DB
    Biomed Pharmacother; 2016 Apr; 79():241-6. PubMed ID: 27044834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine and Human-Purified very Small Embryonic-like Stem Cells (VSELs) Express Purinergic Receptors and Migrate to Extracellular ATP Gradient.
    Bujko K; Brzezniakiewicz-Janus K; Jarczak J; Kucia M; Ratajczak MZ
    Stem Cell Rev Rep; 2024 Jul; 20(5):1357-1366. PubMed ID: 38635127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes of the purinergic signaling system exhibit diverse effects on the degeneration of valvular interstitial cells in a 3-D microenvironment.
    Weber A; Barth M; Selig JI; Raschke S; Dakaras K; Hof A; Hesse J; Schrader J; Lichtenberg A; Akhyari P
    FASEB J; 2018 Aug; 32(8):4356-4369. PubMed ID: 29558203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of purinergic signaling in diabetes: Focus on vascular function.
    Zhou R; Dang X; Sprague RS; Mustafa SJ; Zhou Z
    J Mol Cell Cardiol; 2020 Mar; 140():1-9. PubMed ID: 32057736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Covarrubias R; Chepurko E; Reynolds A; Huttinger ZM; Huttinger R; Stanfill K; Wheeler DG; Novitskaya T; Robson SC; Dwyer KM; Cowan PJ; Gumina RJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1809-20. PubMed ID: 27417582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymes involved in metabolism of extracellular nucleotides and nucleosides: functional implications and measurement of activities.
    Yegutkin GG
    Crit Rev Biochem Mol Biol; 2014; 49(6):473-97. PubMed ID: 25418535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
    Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
    FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinergic signaling: a potential therapeutic target for ischemic stroke.
    Wang L; Li YJ; Yang X; Yang B; Zhang X; Zhang J; Zhang Q; Cheng XD; Wang JH; Yu NW
    Purinergic Signal; 2023 Mar; 19(1):173-183. PubMed ID: 36370253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs.
    Reutershan J; Vollmer I; Stark S; Wagner R; Ngamsri KC; Eltzschig HK
    FASEB J; 2009 Feb; 23(2):473-82. PubMed ID: 18838482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes.
    Clifford EE; Martin KA; Dalal P; Thomas R; Dubyak GR
    Am J Physiol; 1997 Sep; 273(3 Pt 1):C973-87. PubMed ID: 9316419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectonucleoside triphosphate diphosphohydrolases and ecto-5'-nucleotidase in purinergic signaling: how the field developed and where we are now.
    Zimmermann H
    Purinergic Signal; 2021 Mar; 17(1):117-125. PubMed ID: 33336318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.